Connect with us

Banks

Peter Thiel-Backed Psychedelic Start-Up, ATAI Life Sciences, Increases Stake in Compass Pathways

Published

on

Biopharmaceutical conglomerate ATAI Life Sciences (NASDAQ: ATAI), a Peter Thiel-backed psychedelic startup that currently has 10 psychedelic programs in the works, has upped its stake in Compass Pathways (NASDAQ: CMPS), a drug developer looking to accelerate patient access to psilocybin therapy for treatment-resistant depression.

In recent days, Atai Life Sciences (Compass’ biggest shareholder) increased its ownership in Compass Pathways buying another 619,095 shares, taking its stake in the company from 19.4 to 20.8 percent.  

Christian Angermayer, founder and chairman of Atai, explained to CNBC why the company has an interest in backing research into Compass’ psilocybin therapy to treat depression. “The current treatments which are out there are definitely not sufficient,” Angermayer said. “I don’t want to say they don’t work at all because some people are helped by them, but they’re not sufficient.”

Research into psychedelic therapies is an expanding field that seeks to offer alternative treatments, for instance, to the more than 50 percent of patients receiving therapy for major depressive disorder (MDD) who do not respond to approved depression medications.

The move by Atai follows a recent announcement from Compass …

Full story available on Benzinga.com

Original Source: benzinga.com

Banks

If You’re Selling Nvidia Stock Because of Arm Deal Developments, Jim Cramer Thinks ‘You’re a Fool’

Published

on

By

Who is selling NVIDIA Corporation (NASDAQ: NVDA) with the stock already down more than 20% this month? That’s the question Jim Cramer pondered Tuesday when he analyzed the semiconductor stock on CNBC’s “Mad Dash” segment. 

What Happened: Nvidia continued on its downward trajectory Tuesday morning after a Bloomberg report suggested the company is “quietly” preparing to abandon its purchase of British chipmaker Arm Ltd. from SoftBank Group.

According to the report, Nvidia told its partners it doesn’t expect the transaction to close, …

Full story available on Benzinga.com

Continue Reading

Banks

Big Data Platform Market Outlook 2022 to 2031 – Microsoft, Google, Aws, Ibm the Oxford Spokesman

Published

on

Big Data Platform Market Outlook 2022 to 2031 – Microsoft, Google, Aws, Ibm The Oxford Spokesman The Oxford Spokesman

Original Source: oxfordspokesman.com

Continue Reading

Banks

Nvidia Quietly Looks to Dump Its Arm Ambitions

Published

on

NVIDIA Corp (NASDAQ: NVDA) is quietly preparing to abandon its purchase of Arm Ltd from SoftBank Group (OTC: SFTBY) (OTC: SFTBF) on bleak prospects of winning approval for the $40 billion chip deal, Bloomberg reports.
Nvidia expressed pessimism to its partners regarding the …

Full story available on Benzinga.com

Source Here: benzinga.com

Continue Reading

Trending

Chimed.com